Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Lauffer

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chemical Reviews|December 26, 2001
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsP Caravan, J J Ellison, T J McMurry, et al.
Magma (New York, N.Y.)|June 8, 2001
Magnetic resonance angiography at 0.3 T using MS-325K M Lahti, R B Lauffer, T Chan, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Albumin binding of paramagnetic hepatobiliary contrast agents: enhancement of outer sphere relaxivityR B Lauffer, D R Betteridge, S Padmanabhan, et al.
Magnetic Resonance in Medicine|June 11, 1998
Three-dimensional MRI of coronary arteries using an intravascular contrast agentD Li, R P Dolan, R C Walovitch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1984
Contrast agents and spectroscopic probes in NMRJ A Koutcher, C T Burt, R B Lauffer, et al.
Investigative Radiology|December 24, 1997
Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imagingD J Parmelee, R C Walovitch, H S Ouellet, et al.
Magnetic Resonance in Medicine|August 1, 1986
1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein-chelate conjugatesR B Lauffer, T J Brady, R D Brown, et al.
Radiology|January 1, 1991
MR imaging of blood-borne liver metastases in mice: contrast enhancement with Fe-EHPGF Shtern, L Garrido, C Compton, et al.
Magnetic Resonance in Medicine|April 1, 1996
Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRIC Petré, Y Ni, G Marchal, et al.
Magnetic Resonance in Medicine|June 1, 1987
Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivativesR B Lauffer, A C Vincent, S Padmanabhan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemical Reviews|December 26, 2001
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsP Caravan, J J Ellison, T J McMurry, et al.
Magma (New York, N.Y.)|June 8, 2001
Magnetic resonance angiography at 0.3 T using MS-325K M Lahti, R B Lauffer, T Chan, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Albumin binding of paramagnetic hepatobiliary contrast agents: enhancement of outer sphere relaxivityR B Lauffer, D R Betteridge, S Padmanabhan, et al.
Magnetic Resonance in Medicine|June 11, 1998
Three-dimensional MRI of coronary arteries using an intravascular contrast agentD Li, R P Dolan, R C Walovitch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1984
Contrast agents and spectroscopic probes in NMRJ A Koutcher, C T Burt, R B Lauffer, et al.
Investigative Radiology|December 24, 1997
Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imagingD J Parmelee, R C Walovitch, H S Ouellet, et al.
Magnetic Resonance in Medicine|August 1, 1986
1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein-chelate conjugatesR B Lauffer, T J Brady, R D Brown, et al.
Radiology|January 1, 1991
MR imaging of blood-borne liver metastases in mice: contrast enhancement with Fe-EHPGF Shtern, L Garrido, C Compton, et al.
Magnetic Resonance in Medicine|April 1, 1996
Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRIC Petré, Y Ni, G Marchal, et al.
Magnetic Resonance in Medicine|June 1, 1987
Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivativesR B Lauffer, A C Vincent, S Padmanabhan, et al.
Pageof 3